Compounds > piperacillin--tazobactam-drug-combination

piperacillin--tazobactam-drug-combination and Leukemia--Myeloid

piperacillin--tazobactam-drug-combination has been researched along with Leukemia--Myeloid* in 1 studies

Other Studies

1 other study(ies) available for piperacillin--tazobactam-drug-combination and Leukemia--Myeloid

ArticleYear
Central line-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myeloid leukaemia in Piraeus, Greece.
    Journal of medical microbiology, 2006, Volume: 55, Issue:Pt 8

    A case of central venous catheter-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myelogenous leukaemia is reported. The patient was successfully treated with amikacin and piperacillin-tazobactam. The clinical isolate was identified as R. mucosa by 16S rRNA gene sequencing.

    Topics: Acute Disease; Adult; Amikacin; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bacteremia; Base Sequence; Catheterization, Central Venous; Cytarabine; Humans; Leukemia, Myeloid; Male; Methylobacteriaceae; Molecular Sequence Data; Neutropenia; Penicillanic Acid; Phylogeny; Piperacillin; Piperacillin, Tazobactam Drug Combination; RNA, Bacterial; RNA, Ribosomal, 16S; Vidarabine

2006